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ABSTRACT 
The hypothesis that solid particles may be encapsulated by 
coacervation led to the investigation of the extractability of micro-
capsules,which contained solids, by gastrointestinal fluids. Starting 
pH, starting temperature, ratio of solid to encapsulating materials, 
quantity of denaturant, and final pH were varied. In a ddition a sur-
factant and dispersant were added to selected series. The effects 
of the variables and additives on microcapsules were determined by 
submitting samples to simulated gastrointestinal fluids for periods 
of up to two and one-half hours and then comparing the extracts 
spectrophotometrically to know absorption spectra. Results 
showed that all variables and additives effected some degree of 
change in microcapsules. 
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I. INTRODUCTION 
The term coacervation has had a long and diversified history. 
It was used as early as 1398 to mean, "a 'heaping together, 1 either of 
people or things' (1). It has more recently been adopted by chemists 
to describe the salting out of a lyophilic solid into liquid droplets 
rather than solid aggregates (2). The term was first introduced into 
colloidal chemistry by Kruyt and Bungenberg de Jong (3) to describe 
the flocculation or separation of liquids from solution when at least 
one of the liquids contained a macromolecular or colloidal solute. 
Coacervation has been sub-divided by Bungenberg de Jong (4) into 
simple coacervation and complex coacervation; simple coacervation 
describes a system which requires that only one colloidal solute be 
present, while complex coacervation describes a system containing 
more than one colloid. 
According to this same author (5) simple coacervation is the ag-
gregation or flocculation of a dispersed hydrophilic colloid brought 
about by the addition of a strongly hydrophilic substance, to produce 
a water deficit in a part of the system. Simple coacervation can be 
accomplished by mixing two colloidal dispersions each of which con-
tains a concentration of colloid from approximately 20 to 40 per cent; 
o,r it can be induced in a dispersion of a less concentrated, single 
6 
( 
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colloid by adding alcohol, sodium sulfate, or resorcinol. In either 
case, it is possible to redisperse the aggregated colloidal droplets by 
the addition of water. Neither the isoelectric point of the colloid nor 
the presence of indifferent salts is of any significance to the process 
of simple coacervation; the principal requirement here is merely the 
creation of an insufficiency of water in a part of the total system (6). 
Complex coacervation can be induced in systems having two dis-
persed hydrophilic colloids of opposite electrical charges. Bungenberg 
de Jong stated that, in a system of gum arabic and gelatin, complex 
coacervation always occurs at pH values below the isoelectric point of 
the gelatin and maintained that this was true "however one changes the 
other factors" (7). 
He explained that the apparent equivalent weight of the gelatin and 
gum arabic depended on the isoelectric point of the gelatin and the pH 
of the system (derived from the dissociation of the carboxyl groups). 
The optimum pH for complex coacervation was that pH at which equiva-
lents of oppositely charged micelles were present, since at that point 
the greatest possible number of salt bonds were formed and the highest 
degree of coacervation occurred. Therefore, in such a system, the pH 
should be adjusted so that the gelatin particles are positive, since gum 
arabic particles are always negative in colloidal dispersion:{$.). 
It was also observed that the practical limits of concentration of 
each colloid, within which complex coacervation occurred, were be-
tween O. 001 and 5 per cent (9). The upper limit was explained by the 
( 
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presence of the indifferent salt, calcium chloride, derived from calcium 
and chloride ions present in acacia and gelatin, respectively. Indifferent 
salts, such as calcium chloride, hinder coacervation because of the 
"double valency rule 11 (10). 
Although simple and complex coacervation yield essentially the 
same type of products, the conditions necessary for the agglomeration 
of each of them differ considerably. When all of the factors are con-
sidered, the principal condition for simple coacervation becomes an 
insufficiency of water in part of the system. Complex coacervation, 
however, will not occur even if the concentration of colloids falls with-
in the prescribed limits and the indifferent salt concentration is suf-
ficiently low. The principal condition required for complex coacerva-
tion is adequate opposition of charge between two colloids, which can 
be brought about by adjustment of pH. Minimal hydration of ions, the 
required condition for simple coacervation, is accomplished by the re-
moval of water. Since pH can be precisely adjusted, and since the 
hydration process is more difficult to control, this study was concerned 
primarily with microencapsulation using complex coacervation. 
Green and Schleicker ( 11) have made practical use of coacervation 
in a patented process of microencapsulation. In this process, capsules 
were formed either by the reaction of two oppositely charged dispersed 
colloids or by precipitation of one dispersed colloid through the action 
of a strongly hydrophilic substance. Although encapsulation using a 
( 
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single colloid was not carried out ex per:iine ntally, it should be noted that 
procedures for such entrapment are to be fou nd in t h e United States 
Patents: No. 2,730 , 457 (11) , No. 2,712 , 507 (12), No. 2,730,456 (13), 
No. 2, 800, 456 (14), No. 28, 800, 458 (15) , No. 3, 137, 631 (16), and 
No. 3, 155, 590 (17). 
Various patents issued to Green and Schleicker ( 13, 18) indicate 
that paraffin oil, castor oil, sperm oil, lard oil, methyl salicylate, 
and trichlorodiphenyl have been entrapped in ge l atin-acacia microcap-
sules. At least some of the oils contained dissolved substances, such 
as Sudan III dye, crystal violet lactone, malachite green lactone, and 
benzoyl leuco methylene blue. It is interesting t o note that these patent 
holders claimed to be able to coacervate with concentrations of gelatin 
and gum arabic up to 14 per cent. The ability to coacervate at con-
centrations in excess of 5 per cent may have been due in part to the 
nucleating power of the oil droplets present in this system, which 
were not present in the Bungenberg de Jong system. 
The process by which oils were encapsulated by Green and 
Schleicker was relatively simple. Dispersions of gelatin and acacia 
in water were made at 55°C. and the pH of each was adjusted to a 
value just below the isoelectric point of the gelatin. An oil-in-water 
emulsion was then formed using the acacia and/or gelatin dispersions 
as the emulsifying medium. When only one of the colloidal dispersions 
was included in the emulsifying medium., t h e s e c ond dispersion was 
10 
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I added following completion of emulsificat ion. Then, the pH was ad-
justed to a value even farther below the isoelectric point of t he gelatin 
and a solution of formaldehyde in water was added. Then, the tempera-
ture was reduced from 5 o0 c. to 1 o0 c. and the pH was raised to a value 
above the isoelectric point of the gelatin. The viscosity was adjusted 
by evaporation or by addition of water, to prepare the product for its 
ultimate use. The authors pointed out that the product could be pre-
pared as a free flowing powder, either by spray or oven drying. 
Conditions for encapsulation of oils other tha n those mentioned above 
were not given, nor was a method to evaluate the strength or degree of 
encapsulation elucidated (11, 13). 
Luzzi and Gerraughty (18), in a study to determine the permeability 
of the capsule wall, assayed microcapsules containing modified mineral 
oil. The mineral oil was modified so that it possessed a range of 
saponification values and acid values, as well as surfactant properties. 
The samples were extracted, for varying periods of time, using ethyl 
ether; the liquid extracts were diluted with the solvent and assayed for 
oil content by spectrophotometric means. It was found that , although 
saponification value had little effect upon the permeability of the cap-
sule wall, higher acid values and surfactants increased wall permea-
bility. 
Miller and Anderson (1 7) , using a system of cyclohexane , butyl 
rubber, aspirin, and ethyl cellulose prepared a sustained action, solid 
( 
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dosage form of aspirin. The authors claim a 92% aspirin content for 
their product; however, the assay method they use d was not disclosed. 
This system may be thought of as encapsulation by means of simple_ 
coacervation, since it relied on the solubility of the encapsulating 
agent as a function of variable temperature. The authors have con-
trolled the apparent required amount of solvent through variation of 
temperature as Bungenberg de Jong controlled available water by salt 
content. 
Phares and Speradino (19), in a summary, state, "Almost any 
insoluble particle can be coated with coacervate drops. 11 The authors 
of Microcapsulation (20) enumerate several solid and liquid materials 
which have been encapsulated by coacervation. None of these sources, 
however, makes an attempt at predicting the rate at which the encap-
sulated substance will be released. 
In pharmacy, as well as in other areas (20), encapsulation 
through coacervation has great potential practical application. Some 
properties of these microcapsules which would be especially useful 
to pharmacy include: the ability to prevent vaporization of any volatile 
substances ( e. g. , peppermint oil); the ability to protect moisture 
sensitive and light sensitive substa nces (e.g., vitamins A and K); the 
ability to separate physically incompatible materials within a single 
system; the ability to disperse water -insoluble substances more 
readily in an aqueous medium; and, the ability to prolong the action 
( 
( 
of certain drugs when they have been ingested. 
The effectiveness of a drug is dependent, above all, upon its 
availability to the body. A substance which is encapsulated is not 
immediately available. The capsule wall must be penetrated or must 
be conducive to a leaching action, or both. In either case, deviations 
from the prescribed method of microcapsule manufacture, along with 
suitable assay methods, should be investigated and the results con-
sidered when a pharmaceutical dose form is to be prepared. This is 
especially applicable when the drug is to be embodied in a sustained 
or prolonged release type of medication. 
With these considerations in mind, the system of Luzzi and 
Gerraughty (18) was examined. It was the intention of this study to 
develop a means to encapsulate solids through complex coacervation 
and to determine: 
12 
( 1) the effects of varying the starting pH, the starting tempera-
ture, the quantity of denaturant, the ratio of material to be encap-
sulated to encapsulating agents, the final pH, and the effect of certain 
surfactants and deflocculants on the permeability of capsule shell when 
in contact with gastrointestinal fluids; and 
(2) to develop a method for the evaluation of the effect of such 
variation on the system. This study was designed so that the suscep-
tibility of the capsule wall to the action of gastrointestinal fluids could 
be determined. 
( 
( 
II . EXPERIMENTAL 
PREPARAT ION OF MICROCAPSULES 
The basic procedure employed by Luzzi and Gerraughty (18 ) for 
the preparat ion of microcapsules was used . The primary enc apsulat -
ing solutions we r e m a de by dissolving 3 . 0 Gm. of acacia and 3. 0 Gm. 
of gelatin separate l y in 100 m l. of pur·'fied water at 55°C . The acacia 
used was pow dered A c acia , U . S. P .; the gelatin used was 3 00 bloom 
pigskin gelatina w i th an isoelectric point at pH 8 . 0. 
A 20% sodium hydroxide solution was used to adjust the starting 
pH of the solutions t o 6. 5 . A c acia particles in solution are negative l y 
charged and a t t h i s pH the gel atin particles are sufficiently negative 
so that they will not i nteract with the acacia. 
An emulsion was formed by a dding 12 ml. of oil to the a cacia 
solution. The gelat in s o lution was then added to the emulsion , with 
gentle stirring. 
The pH of t he m ixture was then adjusted to 4 . 5 by the d r opwise 
addition of Diluted Hyd rochloric Acid , U . S . P ., while stirring. At 
this pH, the ge latin particles were positively charged and were at-
tracted to the n egative acacia particles . The combined particles 
coalesced about t he oil droplets c.nd i solated them from the re st of the 
(a) The Ame r i can Agricultural Chc:mical Company , Detroi t , M i chigan 
13 
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system. 
At this point, 10 ml. of Formaldehyde Solution, U.S. P., were 
added to the mixture and it was cooled to 1 o0 c. by immersion in an 
ice bath. The pH was then adjusted to a final pH of 9. 0 by the drop-
wise addition of 20% sodium hydroxide solution. The addition of the 
formaldehyde denatured the coagulated gelatin-acacia complex and en-
trapped the oil droplets more permanently than before. Chilling of the 
coacervate helped to set the gelatin-acacia film~ making it even less 
permeable. The pH adjustment also enhanced this effect. 
The mixture was then diluted to approximately 400 ml. with dis-
tilled water and then filtered through filter paper. The wet mass was 
firmly wrapped in blotting paper to remove some of the excess mois-
ture. The resulting soft, rubbery mass was then passed through a 
20 mesh screen and dried at 50°C. for 24 hours. The dilution of the 
mixture facilitated filtration and allowed removal of some of the ex-
cess formaldehyde. The precipitate, after being dried, was coarsely 
granular. 
The above procedure was altered in the following ways: 
( 1) the starting pH was varied between 5. 0 and 7. O; 
(2) the ratio of mater ial to be encapsulated to encapsulating 
materials (dry weight) was varied from 2 / 6 through 20 /6; 
(3) the quantity of formaldehyde solution was varied from 
1 ml. to 20 ml. for each 100 ml. of 3% gelatin dispersion; 
{ 
(4) the starting temperature was varied from 34°C. to 42°c.; 
(5) the final pH was varied from 6. 5 to 8. 8; and, 
15 
(6) solid particles, all of which passed through a U.S. P. 60 mesh 
screen, rather than oil droplets, were encapsulated. 
In addition, Tween 20 and Darvan 7 were added in various quanti-
ties to the aqueous phase prior to the addition of the solid. In order to 
minimize the degradation of pentobarbituric acid, the temperature at 
which the capsules were dried was reduced from 50°C. to 40°C. All 
data reported in the section dealing with results are averages of dupli-
cate determinations of two or more samples. 
CHOICE OF MATERIALS 
The primary objective of this research was to determine whether 
or not a solid particle could be encapsulated by this particular process . 
Preliminary investigation brought forth the facts that: 
(1) the solid to be encapsulated should be insoluble, or nearly so, 
iri the system; 
(2) the solid particles should be readily dispersible in either 
gelatin or acacia solution; 
(3) the solids should contribute no surfactant qualities; 
(4) the solid should be quickly soluble when e xposed to the 
proper solvent; 
(5) the solid should not degrade appreciably when exposed to 
.. ' 
( 
( 
16 
aqueous systems for several hours; 
(6) the solid should preferably be of a pharmaceutical nature. 
The following solids were chosen and encapsu lated: colloidal 
sulfurb, special flowers of sulfurc, aspirin anhydride (recrystal-
lized from ethyl acetate solution to a M. P. of 81°c. -83°C. )d, Aceto-
phenetidin, U.S. P., barbituric acide, lycopodium sporese, DDTf, 
pentobarbituric acid (M. P. 127°-128°c. )g, and carbon blackh. 
Since sulfur was available in a variety of p a rticle sizes and be-
cause it seemed to conform to all of the other requirements, several 
samples of microcapsules containing it were prepared. However, con-
' 
siderable difficulty was encountered when attempts were made to assay 
the sulfur capsules. Although it first appeared that sulfur could be 
assayed by a simple gravimetric method, it was found that when it was 
encapsulated and still wet from immersion in gastrointestinal fluids, 
the sulfur was, at best, only slowly extractable by carbon disulfide, 
This was true even when the capsules were previously crushed by 
mechanical means. 
(b) 
(c) 
(d) 
(e) 
(£) 
(g) 
(h) 
SulfidalR, Heyden Chemical Corp., New York 17, New York 
Stouffer Chemical Co., 380 Madison Ave., New York 17, New York 
The Upjohn Co., Kalamazoo, Michigan 
Amend Drug and Chemical Co., 117 East 24th St., New York, 10, 
New York 
1, 1, l-trichloro-2, 2-bis (p-chlorophenyl) ethane, Technical 
Grade, Matteson, Coleman & Bell, East Rutherford, New Jersey 
"Acid Nembutal," Abbott Laboratories, North Chicago, Illinois 
) 
"UCET" Acetylene Black 50% Compressed, Union Carbide Corp. , 
Olefin Division, 270 Park Ave., New York, New York 
( 
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Aspirin anhydride offered the advantages that it was less sol-
uble than acetylsalicylic acid and that a prolonged release dosage form 
would probably prove commercially valuable. However, its stability 
to hydrolysis was not sufficient for the conditions of this project. 
Lycopodium spores and carbon black were encapsulated in an 
attempt to obtain more informative photomicrographs. However, 
neither of these substances could be assayed by a simple method. 
DDT, on the other hand, would have had to be extracted (as was 
sulfur) from aqueous media to a non-aqueous media before assays 
could be carried out. 
The choice was therefore narrowed to barbituric acid and 
pentobarbituric acid, In the case of both barbiturates the advantage 
was apparent from the fact that both were insoluble in acid aqueous 
media but soluble, as their salts, i:Q. alkaline aqueous media. 
Since, at that time, an in-vivo assay was contemplated and be-
cause the hypnotic effect of pentobarbituric acid is shorter than 
that of barbituric acid, the former, rather than the latter, was 
chosen to demonstrate the effect of the variables discussed earlier. 
This choice, however, limited the range over which certain of the 
variables could be tested. It became obvious, for example, that 
the starting hydrogen ion concentration must be kept above that 
at which significant quantities of pentobarbituric acid would be 
soluble. 
18 
METHOD OF EVALUATION OF MICROCAPSULES 
The method used to evaluate the susceptibility of the coacervate 
shell to the action of U.S. P. simulated gastrointestinal fluidsi was 
based principally on the ability of the fluids to expose and/ or extract 
the encapsulated material. In order to determine the degree of des-
truction or permeability, or both, caused by the gastrointestinal fluids, 
a spectrophotometric method of assay was devised. 
The microcapsules were prepared in the manner previously des-
cribed and 0. 25 Gm. samples of the dried capsules were exposed to 
gastric and intestinal fluids. The samples were fir st exposed con-
secutively, then separately to 100 ml. of gastric fluid and 100 ml. of 
intestinal fluid, employing a Burrell Wrist Action Shakerj. 
In the first instance, the samples remained in contact with 100 ml. 
of gastric fluid for O. 5 hours, were filtered, and the filter paper and 
remaining sample were then transferred to 100 ml. of intestinal fluid; 
the filter paper was broken up prior to immersion in intestinal fluid . 
A 1. 0 ml. sample was withdrawn through a cotton pledget after one hour 
exposure to intestinal fluid and, after two hours, the intestinal fluid 
was removed from the sample by filtration. 
In the second instance, the samples were allowed to remain in con-
tact with the gastric fluid for O. 5 hours. Duplicate samples were 
(i) U.S. P. XVI, pp. 1072-73 
(j) Burell Corp., Pittsburg, Pennsylvania 
( 
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prepared and allowed to remain in contact with intestinal fluid for one-
half and one hour periods. 
The removal of the sample from gastrointestinal fluids was pre-
ceded in each instance by the adjustment of pH to 9. 25. If the sample 
were to remain in a fluid for further extraction, the pH was again ad-
justed to official (U.S. P.) suggested values for that fluid. Diluted 
Hydrochloric Acid, U.S. P. and 20% sodium hydroxide solution were 
used for the adjustments. 
Pentobarbituric acid has a pKa of 8. 11 (21) and, therefore, at 
pH 9. 1 the ratio of sodium pentobarbital to pentobarbituric acid be-
comes ten to one. Spectrophotometric studies of solutions of sodium 
pentobarbital indicated that adsorption increased with increased pH 
values and that at pH 9. 0, as may be predicted by theory, a gradual 
decrease in the slope of the curve occurred. Since pH values of 9. 25 
co\,lld be achieved with relative accuracy (+ 0. 05 pH units) and ease, 
and since a great majority of the solute is in the salt form at this pH, 
this was the pH at which all liquid filtrates were compared. 
The liquid filtrates, after exposure to the gastric fluid, were 
assayed for content of active constituent as were the liquid filtrates 
after exposure to intestinal fluid. The solutions were scanned for 
wavelength of maximum absorption using a recording spectrophoto-
meterk. A broad peak was found with a maximum at 241 to 242 mJ'(. 
(k) Bausch & Lomb "Spectronic 505, "Bausch & Lomb Optical Co. , 
Rochester, New York 
( 
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Beer's Law plotsl were prepared using a B e ckman spectrophotometerm. 
The concentration of the liquid filtrates obtained by the extraction 
methods already described, were determined by comparing their res-
pective Beer's Law plots to the absorbance observed. 
The total quantity of pentobarbituric acid in each sample was found 
by disintegrating a known weight of capsules in a Virtis blendern with a 
known volume of distilled water at pH 9. 2 5, the sample was filtered and 
the resulting liquid adjusted, if necessary, to pH 9. 25 . Aliquots were 
prepared and spectrophotometric data w ere collecte d which, when 
compared to the Beer's Law Plot of Figure III (p. 2 3 ), yielded the in-
formation from which the calculations for total pentobarbituric acid 
content were carried out. 
(1) See figures on pages 21, 22 and 23. 
(m) Beckman D. U. Spectrophotometer, Beckman Instruments, Inc., 
Fullerton, California 
(n} Virtis 1145," Precise Products Corp. , Racine, Wisconsin 
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III. RESULTS 
EFFECT OF STARTING@ ON MICROCAPSULES 
Each sample in this series was prepared by a method designed 
to determine the effects of different starting hydrogen ion concentra-
tions on the microencapsulation of pentobarbituric acid. That is, all 
aspects of the preparation of each sample remained constant throughout 
with the exception that the starting pH was varied from pH 5. 0 through 
pH 7. O. 
Two factors were primarily responsible for the choice of thes e 
limits. Firstly, it was observed that systems prepared using only 
gelatin and acacia be.came slightly cloudy even at pH values just above 
pH 5. 0, an indication that the point of complete coacervation was being 
approached so that the lowest practical starting pH was established to 
be 5. 0. Secondly, since the salt-acid ratio of sodium pentobarbital-
pentobarbituric acid increased from 1. 26 at pH 7. 0 as the pH increased 
and since the salt was soluble in alkaline aqueous media, the examina-
tion of microencapsulation at starting pH values greater than 7. 0 was 
not practical. 
A series of s amples ranging from pH 5. 0 to pH 7. 0 was prepared 
and 0. 25 Gm. of each were assayed in the manner previously describ-
ed. Table I shows that, throughout the entire series, the maximum 
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TABLE I 
EFFECT OF STAR TING pH ON THE % OF PENTOBARBITURIC 
ACID EXTRACTED FROM MICROCAPSULES EXPOSED 
TO GASTROINTESTINAL FLUIDS* 
Starting pH after 1 /2 after 1 after 2 total in 
hr. in hr. in hrs. in gastric and 
gastric intestinal intestinal intestinal 
fluid fluid fluid fluids 
5.0 33.8 15. 9 24.0 57.8 
5.3 27.0 14.8 26.9 53.9 
6.0 30. 1 13. 3 23.6 53.7 
6. 5 23. 7 10.9 29.3 53.0 
7.0 30.5 13. 3 24.0 54.5 
*All values expressed as % of total pentobarbituric acid found 
in microcapsules. 
Note: After removal of gastric fluid the samples were trans-
ferred to intestinal fluid. 
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difference in per cent of total of pentobarbituric acid released after 2. 5 
hours of exposure to gastro-intestinal fluids was only 4. 8. The differ-
ence in per cent released was somewhat greater (9. 9) after one-half 
hour exposure to gastric fluid alone, Table II indicates that after one 
hour exposure to intestinal fluid the maximum difference in total per 
cent released was 3. 1. Under all the test conditions, the samples 
seemed to remain in the same relative positions with respect to acid 
released. 
EFFECT OF STARTING TEMPERATURES ON MICROCAPSULES 
Gelatin-acacia systems, in the concentrations used for this pro-
ject, became gels at slightly above room temperature but became less 
viscous as the temperature of the systems was raised, For this reason 
and since the solubility of pentobarbituric acid increased with increas-
ing temperature, it was desirable to examine the effects on microen-
capsulation by' varying the starting temperature. 
Tables III and IV show that the range of starting temperatures 
employed was between 34°C. and 42°C. In all cases observed, except 
after 0, 5 hours in gastric fluid, the per cent of pentobarbituric acid 
that was released was found to be at a maximum at 34 °C. starting 
temperature and reached a minimum at 37°C. starting temperature. 
EFFECT OF RATIO OF SOLID TO ENCAPSULATING MATERIALS 
During preliminary studies, microscopic examination of micro-
( 
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TABLE II 
EFFECT OF STARTING pH ON THE% OF PENTOBARBITURIC 
ACID EXTRACTED FROM MICROCAPSULES EXPOSED 
TO INTESTINAL FLUID* 
Starting pH after 1 /2 hr. after 1 hr. 
5.0 27. 5 28.0 
5. 3 2 5. 8 24.5 
6.0 18.4 26.5 
6. 5 22.4 24.9 
7.0 2 5. 3 25.2 
*All values expressed as % of total pentobarbituric acid found 
in microcapsules. 
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TABLE III 
EFFECT OF STAR TING TEMPERATURE ON THE % OF PENTO-
BARBITURIC ACID EXTRACTED FROM MICROCAPSU LES 
EXPOSED TO GASTROINTESTINAL FLUIDS* 
Starting after 1 /2 after 1 after 2 total in 
Temperature (oc.) hr. in hr. in hrs. in gastric and 
gastric intestinal intestinal intestinal 
fluid fluid fluid fluids 
34 44.3 24.4 27.6 71. 9 
( 
36 37.8 16.4 25.3 63. 1 
37 36.8 13.2 22.0 58.8 
40 34.8 19.2 26.3 61. 1 
42 38.8 18.9 26.8 65.6 
* All values expressed as % of total pentobarbituric acid found 
in microcapsules. 
Note: After removal of gastric fluid the samples were trans-
ferred to intestinal fluid. 
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TABLE IV 
EFFECT OF STARTING TEMPERATURE ON THE% OF PENTO-
BARBITURIC ACID EXTRACTED FROM MICROCAPSULES 
EXPOSED TO INTESTINAL FLUID* 
Starting Temperature after 1/2 hr. after 1 hr. 
34 32.4 35.6 
36 28. 3 32.9 
37 25. 6 30.8 
40 27. 9 33. 1 
42 2 9. 8 35.0 
*All values expressed as % of total pentobarbituric acid found 
in microcapsules. 
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capsule systems revealed what appeared to be unfilled coacervate drop-
lets (Photograph III, page 51 ). This observation, together with the 
assumption that there may be a practical limit to the quantity of a solid 
that can be added to a given system, prompted examination of systems 
employing different ratios of solids to encapsulating agents. The re-
sults arrived at, using starting temperature as a variable, proved to 
be the most predictable. The series consisted of ratios ranging from 
4. 0 Gm. of pentobarbituric acid to 6 Gm. tota l dry weight of encap-
sulating materials (4/6), through 20, 0 Gm. of acid to 6 Gm. total dry 
weight of encapsulating materials (20/6). With the exception of the 
variable, as noted, all conditions within a series remained unchanged. 
Tables V and VI show that, after assay, the per cent of total acid which 
was released from the samples increased as the ratio of solid to encap-
sulating material increased. Table V, it should be noted, also shows 
that the increase in per cent released, from one to two hour exposures 
to intestinal fluid, decreased as the ratio increased. 
EFFECT OF DIFFERENT QUANTITIES OF DENATURANT ON MICRO-
CAPSULES 
To determine the effects of varying quantities of denaturant added 
to the system, a series of samples was prepared in which the volume 
of 37% formaldehyde solution was varied from one to 20 ml. for each 
100 ml, of 3% gelatin solution, All other aspects of preparation were 
maintained constant throughout the series. 
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TABLE V 
EFFECT OF RATIO ON THE% OF PENTOBARBITURIC ACID 
EXTRACTED FROM MICROCAPSULES EXPOSED TO 
GASTROINTESTINAL FLUIDS* 
Ratio after 1 /2 after 1 after 2 total in 
4/6 
8/6 
12/6 
16/6 
20/6 
hr. in hr. in hrs. in gastric and 
gastric intestinal intestinal intestinal 
fluid fluid fluid fluids 
28.7 13. 3 24.0 42.7 
36.8 13.2 22.0 58.8 
39. 1 18.4 26.6 65.7 
40. 2 26. 1 30.7 70.9 
45. 2 26.2 2 9. 1 74.3 
*All values expressed as % of total pentobarbituric acid found 
in microcapsules. 
Note: after removal of gastric fluid the samples were trans-
ferred to intestinal fluid. 
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TABLE VI 
EFFECT OF RATIO ON THE % OF PENTOBARBITURIC ACID 
EXTRACTED FROM MICROCAPSULES EXPOSED TO 
INTESTINAL FLUID* 
----------------------~---------- -
---- -- --------------------- ----------
Ratio after 1 /2 hr. after 1 hr. 
--
4/6 26.6 28.2 
8/6 25. 6 31. 2 
12/6 39.5 38.5 
16/6 35.5 41. 2 
20/6 41. 4 52.3 
-------
*An values expressed as % of total pentobarbituric acid found 
in microcapsules. 
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Formaldehyde acts as a denaturant to harden and fix in place the 
wet gelatinous shell; and in order to test this effect microencapsulation 
was attempted within the stated range. Tables VII and VIII show that 
1 ml. and 2 ml. quantities of the formaldehyde solution were insuffi-
cient to effect collection of the samples. At a volume of 4 ml. of 
formaldehyde solution the samples became collectable and continued 
to be collectable throughout the remaining range of the series. An in-
teresting observation is that, during initial exposure to either gastric 
or intestinal fluids, the per cent of pentobarbituric acid released from 
the capsules was greatest in those samples to which the largest quanti-
ty of formaldehyde had been added. Table VII also shows that when the 
samples were transferred from gastric fluid to intestinal fluid the 
quantity of acid which was found in the latter decreased with increasing 
quantities of formaldehyde. 
EFFECT OF FINAL .EB ON MICROCAPSULES 
Pentobarbituric acid is very soluble at pH values greater than 
8. 0, and is also relatively insoluble at acid pH values. Considering 
that a pH value of 9. 0 was previously considered optimum (18) for the 
final pH, it was desirable to determine what effect would occur if the 
final pH was varied. 
A series of samples was prepared with final pH values ranging 
between 6. 5 and 8. 8. Tables IX and X show that after initial exposure 
( 
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TABLE Vll 
EFFECT OF FORMALDEHYDE ON THE% OF PENTOBARBITURIC 
ACID EXTRACTED FROM MICROCAPSULES EXPOSED TO 
GASTROINTESTINAL F'LUIDS* 
Formaldehyde after 1 /2 after 1 after 2 total in 
Solution hr, in hr. in hrs . in gastric and 
(ml.) gastric intestinal intestinal intestinal 
fluid fluid fluid fluids 
1 sample not collectable - - - - - - - - - -
2 sample not collectable -
4 40.2 22.6 30.0 70.2 
6 38. 0 16. 6 26.8 64.8 
8 32. 9 17. 3 26.4 59.3 
10 37.8 16. 4 25,3 63, 1 
20 47.8 18. 2 23,8 71. 6 
* All values expressed as % of total pentobarbituric acid found 
in microcapsules, 
Note: After removal of gastric fluid the samples were trans-
ferred to intestinal fluid. 
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TABLE vm 
EFFECT OF FORMALDEHYDE ON THE % OF PENTOBARBITURIC 
ACID EXTRACTED FROM MICROCAPSULES EXPOSED TO 
Formaldehyde 
(ml.) 
1 
2 
4 
6 
8 
10 
20 
INTESTINAL FLUIDS* 
after 1 /2 hr. 
sample not collectable 
sample not collectable 
27.3 
24.4 
23.7 
28. 3 
27.3 
after 1 hr. 
- - - - -
- - -
38.8 
36.3 
37.3 
32.9 
40.5 
*All values expressed as % of total pentobarbituric acid found 
in microcapsules. 
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TABLE IX 
EFFECT OF FINAL pH ON THE % OF PENTOBARBITURIC ACID 
EXTRACTED FROM MICROCAPSULES EXPOSED T O 
GASTROINTESTINAL FLUIDS* 
Final pH after 1 /2 after 1 after 2 total in 
hr. in hr. i n hrs. i n gastric and 
gastric intestinal intestinal intestinal 
fluid fluid fluid fluids 
6. 5 27.0 14.7 23.5 50.5 
7.0 23.7 28.4 29.3 53.0 
7 . 5 29. 4 13. 1 22.4 51. 8 
8.0 28.6 17.7 27.2 55.8 
8.8 36.7 33.7 36.0 72.7 
.,, 
"'All values expressed as % of total pentobarbitur ic acid found 
in microcapsules. 
Note: After removal of gastric fluid the samples were trans-
ferred to intestinal fluid. 
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TABLE X 
EFFECT OF FINAL pH ON THE% OF PENTOBARBITURIC ACID 
EXTRACTED FROM MICROCAPSULES EXPOSED TO 
INTESTINAL FLUID* 
Final pH a fter 1 / 2 hr. a fter 1 hr. 
6. 5 27.5 28. 5 
7.0 22.4 24.9 
7. 5 26.2 31. 9 
8.0 25. 5 29.0 
8.8 31. 4 33. 9 
* All values expressed as % of total pentobarbituric acid found 
in microcapsules. 
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to gastric and intestinal fluids the per cent of acid released at pH 7. 0 
was less than that released at pH 6. 5, Thereafter, a gradual increase 
from the low at pH 7. 0 was noted throughout the remainder of the 
series. 
Table IX indicates that , in assays carried out after one and two 
hour periods on samples transferred from gastric fluid to intestinal 
fluid, the per cent of pentobarbituric acid extracted was erratic, with 
a slight tendency to increase as the final pH was increased. Table IX 
also shows, however, that the overall per cent extracted increased with 
increasing final pH 
( EFFECT OF TWEEN 20 ON MICROCAPSULES 
Luzzi and Gerraughty (18) showed that Tween 20 in concentrations 
of 2% completely inhibited the encapsulation of mineral oil; it was 
thought that the orientation of Tween 20 molecules at the oil-water 
interface acted to prevent shell forming coacervate droplets from be-
coming oriented at the interface of the oil. The preparation of a 
series of microcapsules was undertaken in an attempt to establish 
the effect on microencapsulation of Tween 20 in systems employing 
solid rather than liquid particles. 
In this series the per cent of Tween 20 included in the aqueous 
phase was varied from zero to O. 0142%, the starting pH was 6. 0, the 
starting temperature was 40°C., 8 Gm, of pentobarbituric acid were 
( 
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TABLE XI 
EFFECT OF TWEEN 20 ON THE% OF PENTOBARBITURIC ACID 
EXTRACTED FROM MICROCAPSULES EXPOSED TO 
GASTROINTESTINAL FLUIDS* 
Tween 20 after 1/2 after 1 after 2 total in 
(%) hr. in hr. in hrs. in gastric and 
gastric intestinal intestinal intestinal 
fluid fluid fluid fluids 
34.8 19. 2 26.3 61. 1 
0.0001 35.0 17. 5 26.8 61. 8 
0.0002 33.9 18. 5 27.0 60 .9 
0.0006 32.7 20. 1 28.3 61. 0 
0.0071 34.4 19. 7 28.2 62.6 
0.0142 40.7 20. 0 26. 1 66.8 
*An values expressed as % of total pentobarbituric acid found 
in microcapsules 
Note: After removal of gastric fluid the samples were trans-
ferred to intestinal fluid. 
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included, a volume of 10 ml. of formaldehyde solution was added, and 
the final pH was 7. 5. Table XI shows that under these conditions there 
was no significant change in the per cent of pentobarbituric acid releas-
ed, with the exception that, at the highest concentration of Tween 20, 
there seemed to be an increase in the per cent of acid released. 
EFFECT OF DARVAN 7 ON MICROCAPSULES 
Since the solid particles of pentobarbituric acid tended to settle 
out of suspension and were at times difficult to disperse, the dispers-
ing agent Darvan 7 was added to three separate series. Also, since 
preliminary work indicated that Darvan 7 was basic {pH 8. 5-9. 0) in the 
concentrations used, it was desirable to determine what effects chang-
ing pH would have on the activity of the dispersant. The three series 
differed in that the lowest pH values employed were 4. 0, 4. 8, and 3. 5. 
The samples of Table XII were prepared in an identical manner 
to those in the Tween 20 series, the only difference being that Darvan 
7 rather than Tween 20 was added. At the lowest concentrations of 
Darvan 7 there seemed to be less acid extracted by gastrointestinal 
fluids than even those samples prepared with no dispersant; thereafter, 
the per cent of acid released became greater with increasing additions 
of Darvan 7. 
Where the samples of Table XIII correspond to the Darvan 7 con-
centrations of those in Table XII, they are identical , with the exception 
( 
TABLE XII 
EFFECT OF DARVAN 7 ON THE% OF PENTOBARBITURIC ACID 
EXTRACTED FROM MICROCAPSULES EXPOSED TO 
GASTROINTESTINAL FLUIDS* 
Darvan 7 after 1/2 after 1 after 2 total in 
(%} hr. in hr. in hr s. in gastric and 
gastric intestinal i ntestinal intestinal 
fluid fluid fluid fluids 
34.8 19.2 26.3 61. 1 
0.0195 ,30. 2 18.4 24.6 54.8 
0.0290 35. 0 20. 1 25.6 60. 6 
0.0580 39. 1 22. 1 2 7. 1 66.2 
o. 1160 34.7 19.7 28.1 62.8 
0.1450 43.0 21. 5 26.2 67.2 
0.1740 38.0 23. 1 30.7 68.7 
*All values expressed as % of total pentobarbituric acid found 
in microcapsules. 
Note: After removal of gastric fluid the samples were trans-
ferred to intestinal fluid. 
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TABLE xm 
EFFECT OF DAR VAN 7 ON THE % OF PENTOBARBITURIC ACID 
EXTRACTED FROM MICROCAPSULES EXPOSED TO 
Darvan 7 
(%) 
0.029 
0. 116 
o. 174 
GASTROINTESTINAL FLUIDS* 
after 1 /2 
hr. in 
gastric 
fluid 
42.2 
43.5 
45.3 
48.5 
after 1 
hr. in 
intestinal 
fluid 
21. 7 
21. 2 
16.3 
28.4 
after 2 
hrs. in 
intestinal 
fluid 
25.9 
25.7 
24.7 
30.7 
total in 
gastric and 
intestinal 
fluids 
68.8 
69. 2 
70. 0 
79. 2 
*All values expressed as % of total pentobarbituric acid found 
in microcapsules. 
Note: After removal of gastric fluid the samples were trans-
ferred to intestinal fluid. 
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that the lowest pH in the former was 4. 8 rather than 4. 0. Table XIII 
shows that there was a greater release of pentobarbituric acid as the 
concentration of Darvan 7 was increased and also that all of the sam-
ples of Table XIII released a greater percentage of acid than the 
corresponding members of Table XII. 
All of the samples within the series found in Table XIV were pre-
pared in a manner similar to those of the Tween 20 group above with 
the exception that the lowest pH was at pH 3. 5 rather than at 4. 0. 
Table XIV shows that samples were not collectable until the second in-
crement of Darvan 7 had been added; with the addition of the second 
( 
increment of the dispersant, they became collectable. Increases in 
the concentration of Darvan 7 beyond the point at which the samples 
became collectable could not be studied. 
FORMULATION OF FAST AND SLOW RELEASE MICROCAPSULES 
Using the information gathered from Tables I through XII, an 
attempt was made to formulate microcapsules which would release all 
or nearly all of the pentobarbituric acid which they contained. An 
attempt was also made to formulate microcapsules which would retain 
more than 50% of their original content of acid after 2. 5 hours ex-
posure to gastrointestinal fluids. Samples of both formulations were 
prepared and they were subjected to the gastrointestinal fluids, as 
previously described. 
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TABLE XIV 
EFFECT OF DARVAN 7 ON THE% OF PENTOBARBITURIC ACID 
EX TRAC TED FROM MICRO CAPSULES EXPOSED TO 
GASTROINTESTINAL FLUIDS* 
Darvan 7 after 1 /2 after 1 after 2 total in 
(%) hr. in hr. in hrs. in gastric and 
gastric intestinal intestina l intestinal 
fluid fluid fluid fluids 
- - -
sample not collectable 
- - - - - - - - - - -
-
0.029 sample not collectable -
-
- - - -
0.058 39. 8 24.6 32.5 72.3 
o. 116 40.4 23.4 30. 3 70. 7 
o. 174 41. 3 32. 1 36.7 78. 0 
0.232 41. 0 22.2 29.9 70. 9 
* All values expressed as % of total pentobarbituric acid found 
in microcapsules. 
Note: After removal of gastric fluid the samples were trans-
ferred to intestinal fluid. 
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Samples for fast release microcapsules were prepared using the 
following conditions: the starting pH was 5. 0, the starting temperature 
was 34 °c. , the ratio of pentobarbituric acid to encapsulating agents 
was 20/6, four milliliters of formaldehyde solution was added for each 
100 ml. of 3% gelatin solution and, the final pH was 8. 8. 
Sampil.es for slow release microcapsules were prepared using the 
following conditions: the starting pH was 6. O; the starting temperature 
was 37°C.; the ratio of acid to encapsulatin g agents was 4/6; eight 
milliliters of formaldehyde solution was added; and the final pH was 
6. 5. 
The results of assays for fast release microcapsules revealed that 
4 7. 3% of the drug was extracted after one-half hour exposure to gastric 
fluid, 30. 1 % after being transferred to intestinal fluid and remaining 
immersed for one hour, 31. 2% extracted after two hours in intestinal 
fluid, for a total of 78. 5% released after two and one-half hours ex-
posure to gastrointestinal fluids. 
The results of as says for slow release microcapsules revealed 
that 37. 7% of the drug was released during one-half hour exposure to 
gastric fluid, 16. 0% released after being transferred to intestinal 
fluid and being immersed for one hour and 21. 5% extracted after two 
hours in contact with intestinal fluid, for a total of 56. 2% released 
after two and one-half hours exposure to gastrointestinal fluids. 
In the fast release samples there was a difference of 1. 1 % in total 
( 
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per cent acid extracted between the one and two hour exposure periods 
to intestinal fluid, whereas there was a difference of 5. 5% acid ex-
tracted under the same conditions for the slow release samples, 
Although the per cent of pentobarbituric acid released after the 
two and one-half hour assay period fell somewhat short of the goal of 
this experiment, there seemed to be a significant difference in the 
per cent of acid released between the two types of samples. It should 
be pointed out that although the results found in Table I indicate that a 
starting pH of 6. 5 was optimum for slow release microcapsules, a 
pH of 6. 0 was utilized since the over-all difference between the values 
was not significant and since the acid is less soluble at lower pH 
values. 
MICRO-PHOTOGRAPHY OF MICROCAPSULES 
It is the intent of this section to clarify (through photographs) the 
action of the gelatin-acacia complex as an encapsulating agent as well 
as to underscore the effects of Tween 20 and Darvan 7 on microencap-
sulation. The solid, in this case, pentobarbituric acid, was encap-
sulated in the prescribed manner and photomicrographs were taken of 
the product after filtration and prior to drying . 
The equipment employed consisted of an Exakt a VX-1la 0 camera 
(o) Exakta Camera Co., Bronx River Road, Bronxville, New York 
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mounted on a Spencer binocular microscopeP. All exposures were for 
4 seconds using Panatomic-x film by Kodak. The magnification in 
each photograph was determined by comparison, at similar conditions, 
to a standard ruled slideq. A magnification statute accompanies each 
photograph. 
Photograph I shows a dispersion of pentobarbituric acid particles 
in a 3% gelatin solution. It can be seen that the particles are quite well 
dispersed. The slight haze surrounding the particles is due to the 
movement of the particles probably caused by evaporation of water. 
Photograph II is typical of groups of microcapsules found when 
there is an optimum relationship between solid particles and encap-
sulating agents. All particles are encapsulated and it can be seen that, 
in some cases, the capsules have fused together. It is also apparent 
that in some cases small groups of solid particles are encompassed 
by a single capsule. 
Photograph III depicts both filled and unfilled microcapsules. 
The encapsulated solid in this case is DDT. No explanation of cap-
sule shape can be given at this time. 
Tween 2 0 (0. 0071 %) was added to the system of Photograph IV. 
Both encapsulated and unencapsulated particles are visible. 
(p) American Optical Company, Buffalo 15, New York 
(q) Bousch and Lomb Optical Co., Rochester, New York 
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Photographs of systems containing less surfactant were prepared and, 
although not shown, suggested a progressive interferrence with encap-
sulation as Tween 20 concentration was increased. 
Photographs V, VI and VII are of systems containing 0. 019%, 
0. 029% and 0. 116% of Darvan 2 respectively. In Photograph V it cq.n 
be seen that the particles were not well dispersed and that large 
groups of particles seem to have gathered together to form a large 
group or groups of capsules. This may account for the decreased re-
lease of pentobarbituric acid at this concentration of Darvan 7 (Table 
XII, p. 41). 
Photograph VI was made from microcapsules to which 0. 029% 
Darvan 7 had been added and shows elongated capsules filled with 
solid particles. The elongation of capsules seemed to be typical when 
moderate quantities of this dispersant were used. A comparison of the 
shell thickness of the overall capsules to the shell thickness of capsules 
of previous photos would seem to indicate that high concentrations of 
the dispersant tent to decrease wall thickness. 
Photograph VII was made of microcapsules containing 0. 116% 
Darvan 7. Although the enlargement in this case was less than in 
preceding ones, it can be seen that the solids are in smaller groups, 
that the capsule shells are quite thin, and that some capsules are not 
filled. 
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IV DISCUSSION 
Microenc apsulation of finely divided solids occurs when 
c6acerv a te dropl ets fo r m about the s o lid particles, but the manner 
i n whi ch the a c tual encapsulation o c curs is not clear. The following 
are two pos s ib l e methods by which encapsula tion may occur. First, 
the capsule fo rma t i on may occur in one step, that is, only one coacer-
vate droplet m a y be required to encompass each particle. If this is 
the case, o ne woul d sus pect that the size of the particle or the method 
of prepar.ati on of the droplet would be of major consideration. 
S e con d, the capsule formation may occur as the result of the 
agglome r ation of m a ny small coacervate droplets about the solid particles 
to form a clo sed c a psu l e which may or may not h e porous. 
In both cases the coacervate capsule may be considered to b e 
prior to drying, made up of hydrated • olloi~al rna,;eri.al. When the 
microcapsule shells are dehydrated, the thickness of the coacervate 
shell is redu c ed and the whole particle is reduced in size. although 
there is no cha nge i n the size of the encapsulated solid. 
P oss ibl e applications of this form of microencapsulation to 
pharmaceuticals l ed to an interest in the possibility of encapsulating 
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solids and to the evaluation of some aspects of the system used to 
prepare the capsules. The solids which were encapsulated by this 
method include: Colloidal sulfur, special flowers of sulfur, aspirin 
anhydride, acetophenetidin, barbituric acid, lycopodium spores, DDT, 
pentobarbituric acid, and carbon black. Pentobarbituric acid was em-
ployed for the collection of all quantitative data presented in this 
thesis. The specific variables chosen for study included starting pH, 
starting temperature, ratio of encapsulated material to encapsulating 
materials, quantity of denaturant, and the final pH. 
It was desirable to obtain some degree of controlled variation of 
these properties, and in this respect all samples within a given group 
were prepared utilizing the same conditions with the exception that 
one of the above variables was altered. However, comparison of re-
sults between series is not valid since factors other than the indicated 
variable may have been altered. It should be explained that at no time 
during the preparation of a given series did any of the variable condi-
tions chosen for examination exceed the limits set forth in the series 
designed to examine the effects of the variable. 
The method of Luzzi and Gerraughty (18) was chosen since this 
investigator was familiar with it and since it offered the opportunity 
to evaluate a unique system for the microencapsulation of solids. 
( 
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EFFEg OF STARTING £!i. ON MICROCAPSULES 
A study of the effect of starting pH on the per cent of pentobarbi-
turic acid released from the various microcapsule samples which had 
been exposed to gastric and intestinal fluids (Table I, p. 25) reveals that 
the quantity of acid released over a 2. 5 hour period did not differ sig-
nificantly. When the samples were exposed only to intestinal fluid 
(Table II, p. 27) for a one hour period, there again seemed to be no 
significant difference in the protection offered, however, examination 
of the data for one-half hour periods in both gastric fluid and intestinal 
fluid indicates a greater variation in the per cent of total acid released. 
The per cent extracted after one-half hour in intestinal fluid is 
probably the least reliable of all the data collected, since during this 
time interval there was no digestion of protein and the only probable 
reactions were a combination of hydration and leaching. In light of the 
above, it would seem likely that as hydration of the shell approached 
completion, the results would become more reliable as well as more 
reproducible. This was found to be the case with samples exposed 
only to intestinal fluid for one hour periods. This supposition was 
further substantiated by the assay results obtained from the consecu-
tive immersions of samples in gastric and intestinal fluids. 
The per cent pentobarbituric acid extracted after immersions in 
gastric fluid for one-half hour indicated no clear trend. It was ex-
pected that the highest per cent releases would occur at pH 5. 0 and 
( 
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pH 7. 0 and although this was the case, the difference between these 
two values and the intervening values was not of such a nature that 
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a definitive judgement could be made. At a starting pH of 5. 0, coa-
cervation was probably partially complete prior to the addition of the 
solid particles, in which case the ratio of encapsulated to encapsulating 
material would have, in effect, been increased. It is quite clear from 
Tables V and VI (pp. 31 and 32) that as this ratio increases the per 
cent of solid released increases. 
At a starting pH of 7. 0 the solubility of pentobarbituric acid, as 
its salt, is theoretically greater than at the other pH values. There-
fore, it is possible to suggest interference with the microencapsula-
tion process. at pH 7. 0, by virtue of the presence of too high a salt 
concentration (10). The possibility also exists that, once converted 
to its solubilized form, the active constituent could have been ad-
sorbed or entrapped by the gelatin or acacia or both and subsequently 
released to the gastric fluid more rapidly than if solubilization had 
not occurred. 
EFFECT OF STAR TING TEMPERATURE ON MICROCAPSULES 
As may be seen fro1n Tables III and IV, the relative position of 
each sample, as to the per cent of pentobarbituric acid extracted, was 
found to remain the same after all time periods. A maximum in per 
cent of acid extracted was found when the starting tempE;irature was 
( 
( 
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34°C. It may be that, at this temperature, the system of gelatin and 
acacia was sufficiently viscous to inhibit the free movement of either 
the colloidal particles, which is necessary for coacervation, or of the 
formed coacervate droplets, which may be necessary if microencap-
sulation is to occur. 
After a minimum was reached, an increase was observed in per 
cent of total acid extracted as the starting temperature was increased. 
This was probably due to the salt-like effect of the greater quantity of 
acid in solution at the higher temperatures. It could also be due, in 
part, to the entrapment by the encapsulating medium of the solubil-
ized acid, thus causing faster initial release rates. The latter specu-
lation is not, however, substantiated by the results shown in Table IV 
(p. 29), when these results are compared to the results of similar 
extraction procedures. 
In light of the above discussion, it is possible to suggest that the 
lower per cent release of acid at the starting temperature of 37°C. 
was due to a combination of (sufficiently low) viscosity and relatively 
low concentration of acid in solution; and converse reasoning would 
probably hold for the higher per cent release at 34°c. 
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EFFECT OF THE RA TIO OF PENTOBARBITURIC ACID TO 
ENCAPSULATING MATERIALS 
The results of this study indicate that, within the range of ratios 
used, pentobarbituric acid was extracted from microcapsules m ore 
rapidly, in all cases, as the ratio of acid to encapsulating agents was 
increased. 
A comparison of the per cent of pentobarbituric acid extracted in 
gastric fluid with the per cent released after the one and two hour ex-
posures to intestinal fluid (Table V, p. 31) indicates that the low ratio 
samples release a higher percentage of remaining acid with increasing 
time. It would be interesting to determine whether or not the low 
( ratio samples would continue to release a greater percentage of the 
remaining acid with the passage of time, however, the available data 
precludes such a determination. 
These results would, however, seem to underscore the theory 
of microencapsulation in which many coacervate droplets agglomerate 
about the particle. In order to conform to this theory, the pre para-
tions with lower ratios would probably have multiple layers of drop-
lets while preparations with higher ratios would have fewer layers. 
EFFECT OF FORMALDEHYDE ON MICROCAPSULES 
The effect of formaldehyde on the permeability of microcapsules 
was determined by varying the quantity of formaldehyde solution add-
ed to the system during the preparation of samples. When no 
( 
( 
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formaldehyde solution was added, and with quantities of up to 2 ml. 
per 100 ml. of gelatin solution, the samples seemed to melt together 
either on reaching room temperature or upon drying at 40°C. with the 
addition of 4 ml., or more, of formaldehyde solution the samples 
maintained a typical appear :;.nce throughout the preparation procedures. 
Because formaldehyde is a d enaturant of protein, it is essential to 
this method of microencapsulation, a fact that seems to be· substantiat-
ed by the difficulty encountered in collection of samples to which little 
or no formaldehyde was added. 
The release of acid from capsules to which 8 ml. of formaldehyde 
solution had been added was at a minimum when exposed to gastro-
intestinal fluids. When the volume of formaldehyde solution was varied 
by 2 ml. in either direction, an increase in the quantity of acid extract-
ed was observed. As the quantity of formaldehyde solution was varied 
further, a greater increase in the per cent of re leased acid was ob-
served. 
The increase in the per cent of acid released at the low formal-
dehyde concentration was probably due to two factors both of which 
could result from inadequate denaturization. First, the gelatin-
acacia shell might not have been sufficiently denatured, thus promot-
ing a partial solubilization of coacervate droplets dur i ng the washi:pg 
procedure to create a thinner or more porous shell; and second, the 
droplets might not have been solubilized during washing but may 
( 
( 
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have been made less impervious to the action of gastrointestinal fluids 
through lack of adequate denaturization. 
Microscopic observations of samples, prior to drying, throughout 
the entire range of this series indicate no appreciable difference in the 
size of the microcapsules. This observation would seem to suggest 
that an increased susceptibility to gastrointestinal fluids was respon-
sible for the rise in per cent of acid extracted from samples to which 
small quantities of formaldehyde had been added. 
The increased per cent of acid that was extracted when greater 
volumes of formaldehyde solution were added to the system was 
probably due to a cracking of the capsule shell on drying. This 
cracking, which resulted in porous capsules, may have resulted 
from excessive denaturization. 
EFFECT OF FINAL~ ON MICROCAPS"gLES 
The samples of this series seemed to show a tendency for the 
microcapsules to give up more of the encapsulated solid as the final 
pH was increased, Since a high final pH acts to fix the coacervate 
droplets in place about the particle to be encapsulated and since pento-
barbituric acid is quite insoluble at pH 6. 5, it was expected that a 
relatively high per cent of acid would be extracted at this pH. It was 
also expected that because of the solubility of the acid at high pH 
values, a maximum per cent extracted would be observed at a final 
( 
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pH 8. 8. The latter expectation was borne ou t i n t h e results found 
in Table IX (p. 3 6 ). 
The re s ults shown in this table w ould seem to indicate that cap-
sules prepared at a final pH 7 . 0 were extracted to a lesser degree by 
gastric fluid and t o a greater degree by intestinal fluid than the rest 
of the series, with the except ion of the final sample. 
At final pH 6. 5 the capsule shells appea r to h a ye been broken 
down more rea dily by gastri c fluid than at pH 7. 0. The possibility 
also exists that at pH 7. 0 the c ap su l es were more firmly fixed and 
less porous than at pH 6. 5 . It i s also possible that a t pH 7. 0 the cap-
1 
sule s were digeste d extensively by the gastric fluid - - to such a degree 
as to eventually allow fas t er l eeching eventually, but not so exce s sive-
ly as to expose the solid complete l y -- thus making the capsule shells 
much more perm e able to extraction when placed in int e s tinal fluids . 
The higher r ates of extract ion at fina l pH values above 7. 0 could 
have resulted from an inc reased acid s o lubility; and the retention of 
the solubilized acid by the capsul e wall during the drying procedure, 
followed by rapi d re lease to the extraction fluids. At final pH 8 . 8 
the quantity of a cid solubilized is probably much greater than a t other 
values us e d; th e salt formed a t pH 8. 8 may hav e acted to reve r se the 
coacervation process causing a general weaken ing of the capsul e shell 
and resulting in greater quantities of extracted. 
( 
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V. CONCLUSIONS 
On the basis of the previous work and the results reported in 
this study, the following conclusions may be drawn -
1. Solids, such as pentobarbituric acid, which are relatively 
insoluble in aqueous systems, can be successfully encapsulated and 
well protected. 
2. In the coacervation process used, starting pH values below 
5. 0, microencapsulation of pentobarbituric acid is inhibited. 
3. The strength of the capsule shell can be controlled by 
changing, either individually or combinations of: the starting tempera-
ture, the ratio of encapsulable to encapsulating materials, the quantity 
of formaldehyde added, and the final pH. 
4. Surfactants or dispersants, in sufficient concentration, in-
crease the rate of release of encapsulated solids to gastrointestinal 
fluids. 
5. The end results of encapsulation may be elucidated by the 
use of microphotographic techniques. 
In order to clarify some of the aspects of this problem, further 
work in the following areas is recommended. 
1. Experiments should be designed that would apply the results 
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obtained in this investigation to the formation of time re l ease medi-
cation. 
2. Controlled combinations of t he variables tested here should 
be examined . 
3. Other prob lems of encapsulation by this method , such as 
lowest encapsulatin g pH, shoul d be examined more tho r oughly . 
4. In order to de t ermi ne the effect of the order of m ixing , other 
surfactants and deflocculants as well as those already used , shou l d 
be introduced at v ari ous points duri ng the preparation of microcap-
sules. 
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5. Encapsulat ion should be attempted using denaturants , such as 
alcohol, rather than fo rmaldehyde. 
( 
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